Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patie...
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study
About this item
Full title
Author / Creator
Luchetti Gentiloni, Michele Maria , Paci, Valentino , Carletto, Antonio , Zabotti, Alen , Ramonda, Roberta , Chimenti, Maria Sole , Dagna, Lorenzo , Luciano, Nicoletta , Piccinelli, Anna , Giovannini, Ivan , Striani, Giovanni , Boffini, Nicola , Sandri, Gilda , Possemato, Niccolò , Pantano, Ilenia , Benfaremo, Devis , Salvarani, Carlo , Ciccia, Francesco , Selmi, Carlo and Moroncini, Gianluca
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Background Upadacitinib (UPA) is a selective JAK inhibitor recently approved for the treatment of psoriatic arthritis (PsA). In this post-approval study, we aimed to evaluate the effectiveness and safety of UPA over 24 weeks and identify clinical predictors of response, in a multicentric cohort of patients affected by PsA. Methods One hundred and t...
Alternative Titles
Full title
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study
Authors, Artists and Contributors
Author / Creator
Paci, Valentino
Carletto, Antonio
Zabotti, Alen
Ramonda, Roberta
Chimenti, Maria Sole
Dagna, Lorenzo
Luciano, Nicoletta
Piccinelli, Anna
Giovannini, Ivan
Striani, Giovanni
Boffini, Nicola
Sandri, Gilda
Possemato, Niccolò
Pantano, Ilenia
Benfaremo, Devis
Salvarani, Carlo
Ciccia, Francesco
Selmi, Carlo
Moroncini, Gianluca
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_108d482682b9424eb9e04468ca9fdd9d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_108d482682b9424eb9e04468ca9fdd9d
Other Identifiers
ISSN
1478-6362,1478-6354
E-ISSN
1478-6362
DOI
10.1186/s13075-023-03182-9
